[The use of raniberl in the combined treatment of peptic ulcer patients].
Kharchenko
N V
NV
Rodonezhskaia
E V
EV
Zagoruĭko
Zh V
ZhV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004382:Duodenitis / Q000188:drug therapy; D004415:Dyspepsia / Q000188:drug therapy; D005260:Female; D005756:Gastritis / Q000188:drug therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D011899:Ranitidine / Q000627:therapeutic use*; D012074:Remission Induction
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D011899:Ranitidine
Primenenie raniberla v kompleksnom lechenii bol'nykh iazvennoĭ bolezn'iu.